View the content of this email online

Flash Therapeutics will be attending the 28th ESGCT Annual Virtual Meeting

ESGCT 2021
Come and meet us. We'll be happy to talk with you about your lentiviral production needs, whether your project is at discovery or clinical stage.
Separator

If you're attending the 2021 ESGCT meeting, we'll be glad to connect and meet with you.

 

Our team will be presenting 2 posters:


"Same lentiviral vector manufacturing process for both research and clinical applications"
Poster ID: P287


"Efficient and safe delivery of multiple mRNA using non-integrative bacteriophage-chimeric retrovirus-like particles for cell therapy and vaccination perspectives"
Poster ID: P196

 

Meet our scientists:

 

 Régis Gayon, Vectorology & Cell Engineering Manager

 

 Christine Duthoit, Ex vivo / in vivo Engineering Manager

 

 

Looking forward to see you there.

To schedule a meeting with our team

Click Here

Follow us

Twitter Flash Therapeutics LinkedIn Flash Therapeutics Youtube Flash Therapeutics Google + Flash Therapeutics
www.flashtherapeutics.com
© Flash Therapeutics 2018

Click here to unsuscribe from the mailing list